drug
CT-101
Phase 2updated 3mo agoby $XAGE Longevity Health Holdings, Inc.
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying CT-101
- phase2A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder
- phase3Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD
- phase3Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 8m ago
Found something off?
comments(0)
5-min edit window · permanent after that